Mission Lifeline Regional Recognition
Mission: Lifeline® Regional Recognition provides a collaborative, annual award opportunity for regions with 3 or more sites participating in Get With Guidelines®-Coronary Artery Disease and submitting STEMI data. Both Receiving and Referring sites may participate in Regional Reporting; STEMI data from all sites in the specified region are included in award determination calculations.
2023 Mission: Lifeline Regional Recognition Measures
- ACE-Inhibitor or Angiotensin Receptor Blocker (ARB) for LVSD at Discharge (AHACAD1): 75% compliance
- Arrival at First Facility to Primary PCI ≤ 120 minutes (AHACAD2): 50% compliance
- Aspirin at Discharge (AHACAD3): 75% compliance
- Beta-Blocker at Discharge (AHACAD4): 75% compliance
- Cardiac Rehabilitation Patient Referral from an Inpatient Setting (AHACAD5): 75% compliance
- ECG within 10 minutes of Arrival at this Center (AHACAD6/AHACAD24): 75% compliance
- High-Intensity Statin at Discharge (AHACAD7): 75% compliance
- Mission: Lifeline EMS First Medical Contact to Primary PCI ≤ 90 minutes OR ≤ 120 Minutes when Transport Time is Prolonged (AHACAD8): 75% compliance
- Primary PCI ≤ 90 minutes (AHACAD9): 75% compliance
How can hospitals participate in Mission: Lifeline Regional Reports and Mission: Lifeline Regional Recognition?
- Enroll in GWTG-CAD
- In the enrollment process, agree to participate in the Mission: Lifeline Regional Reports
- AHA Quality, Outcomes, Research and Analytics Staff will coordinate formal organization and inclusion in a Mission: Lifeline Regional Report
- Submit STEMI Data into GWTG-CAD
- Regional Report data is available in real time via GWTG-CAD's Advanced Analytics platform
How can EMS agencies participate in Mission: Lifeline Regional Recognition?
- Encourage hospital participation in GWTG-CAD
- Once hospital is enrolled in GWTG-CAD, request the hospital complete the process of creating their EMS Agency picker list.
- Actively attend institutional and regional STEMI multidisciplinary meetings
